For more than three years, Éric Roy continued his activity despite illness, guiding Brest towards the most beautiful pages of its history. His death sheds light on a cancer which affects nearly 15,000 people each year in France and whose early symptoms still too often remain unknown.
Éric Roy, a fight fought far from the spotlight
The world of football was shocked to learn of the death of Éric Roy, coach of Stade Brestois, who died at the age of 58 following pancreatic cancer. His family revealed that he had been battling the disease for three and a half years, a battle he chose to fight with great discretion.
Arriving on the Brest bench in January 2023, the former midfielder achieved one of the most notable feats in recent French football. Under his leadership, the Breton club achieved historic qualification for a European competition after an exceptional season in Ligue 1.
Beyond the sporting results, it is above all the image of a deeply invested man that remains. Despite illness, Éric Roy continued to train, prepare for matches and support his players. Those close to him emphasized how football and his work had been a strength in his daily fight.
His disappearance provokes a particular emotion because it recalls the brutality of a cancer whose prognosis remains among the darkest. Often silent for many months, the disease is frequently discovered at an advanced stage, when therapeutic possibilities are already limited.
This reality makes it all the more important to be aware of the first warning signs.
These often trivialized symptoms which should alert
Pancreatic cancer is sometimes referred to as the “silent killer.” The reason is simple: the pancreas is located deep in the abdomen, which makes the tumor difficult to detect early and explains why around 80% of diagnoses are made at an advanced stage.
However, several signals can appear well before diagnosis.
The first concerns unexplained changes in blood sugar. The sudden onset of type 2 diabetes in a person without obvious risk factors, or the sudden worsening of already known diabetes, can constitute a warning signal. As British surgical oncologist Dr Ahmed Ezzat explained: “If the pancreas is dysfunctional, this manifests itself as blood sugar levels that are difficult to control.”
Another frequently overlooked symptom: persistent abdominal or back pain. It often occurs in the pit of the stomach or the middle of the back and can intensify after meals or when lying down. The specialist recalls: “Even if it is not systematic, unexplained pain in these areas should prompt consultation.”
Finally, the
jaundice (jaundice) constitutes one of the most characteristic signs. Even before the skin turns yellow, the change may be visible in the whites of the eyes. Dark urine, discolored or oily stools may also appear when the tumor blocks the bile ducts.
Other manifestations may accompany these symptoms: unusual fatigue, unexplained weight loss, loss of appetite, nausea or persistent digestive problems. The ARC Foundation emphasizes in particular that the disease can manifest itself by unexplained fatigue associated with weight lossas well as localized pain in the stomach or back. These signs, taken in isolation, are frequent and often benign. However, their association or persistence should lead to consulting a health professional.
This difficulty in identifying the first symptoms largely explains the diagnostic delay observed in this disease.
Care that is progressing, despite a major medical challenge
Faced with pancreatic cancer, every week counts. The earlier the disease is diagnosed, the more treatment options there are.
There surgery remains today the standard treatment when a tumor is localized and operable. It constitutes the only possibility of long-term healing. However, not all patients can benefit from it at the time of diagnosis, particularly when the tumor has invaded important vascular structures or has spread distantly.
According to Gustave Roussy specialists, treatment is based on a personalized strategy combining, depending on the situation, surgery, chemotherapy, radiotherapy and supportive treatments. Therapeutic decisions are discussed within multidisciplinary teams bringing together oncologists, surgeons, radiotherapists, gastroenterologists and supportive care specialists.
In recent years, progress has mainly concerned the improvement of chemotherapy protocols and better selection of patients likely to benefit from surgical intervention. Researchers are also continuing their work to identify biomarkers allowing earlier diagnosis and to develop new therapeutic approaches.
Although pancreatic cancer remains one of the most difficult cancers to treat, specialists emphasize an essential message: knowing the early symptoms can speed up diagnosis and improve the chances of treatment.
The disappearance of Éric Roy is a powerful reminder of this reality. Behind the statistics and scientific advances, there are lives, families and journeys of courage. And a collective challenge: better recognize the signs of this silent disease so as not to discover it too late.